Are Industrial Products Stocks Lagging Century Aluminum (CENX) This Year?

Century Aluminum (CENX) has significantly outperformed its Industrial Products sector, achieving a 42.5% year-to-date return compared to the sector's 6.3% average. This strong performance is supported by a Zacks Rank #1 (Strong Buy) and a 29.2% increase in its full-year earnings consensus estimate over the last quarter, indicating robust analyst sentiment and an improving earnings outlook. Similarly, Constellium (CSTM) also demonstrated strong outperformance with a 45.7% YTD return and a Zacks Rank #2, highlighting individual stock strength within the broader industrial segment.

Analysis

Century Aluminum (CENX) is demonstrating significant market outperformance, with its year-to-date return of 42.5% far exceeding the 6.3% average for the broader Industrial Products sector and the 14.2% gain of its direct sub-industry, Metal Products - Procurement and Fabrication. This price momentum is underpinned by a tangible improvement in its earnings outlook, as evidenced by a 29.2% increase in the Zacks Consensus Estimate for full-year earnings over the past quarter. This revision has earned the stock a Zacks Rank of #1 (Strong Buy), indicating a strong positive shift in analyst sentiment. For context, another sector peer, Constellium (CSTM), has also shown exceptional strength with a 45.7% year-to-date return and a #2 (Buy) rank, supported by a 7.9% increase in its own consensus EPS estimate. CSTM's performance is particularly notable as it has occurred while its specific industry group, Metal Products - Distribution, has contracted by 6.8% year-to-date, suggesting powerful company-specific catalysts are at play.

Key Decisions for Investors

• Investors seeking alpha within the Industrial Products sector should consider overweighting Century Aluminum (CENX) and Constellium (CSTM), as both are exhibiting strong price momentum backed by positive earnings estimate revisions.
• The primary driver for CENX is its improving earnings forecast, so investors should monitor forward-looking analyst revisions and earnings reports as key indicators for sustaining its outperformance.
• Given that Constellium's (CSTM) 45.7% gain has occurred despite a 6.8% decline in its direct industry, it may warrant deeper due diligence to identify the idiosyncratic strengths driving its significant market outperformance.